These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 16513852)

  • 1. Stimulant medications: how to minimize their reinforcing effects?
    Volkow ND
    Am J Psychiatry; 2006 Mar; 163(3):359-61. PubMed ID: 16513852
    [No Abstract]   [Full Text] [Related]  

  • 2. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD.
    Volkow ND; Swanson JM
    Am J Psychiatry; 2003 Nov; 160(11):1909-18. PubMed ID: 14594733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
    Kollins SH
    J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys.
    Gasior M; Bergman J; Kallman MJ; Paronis CA
    Neuropsychopharmacology; 2005 Apr; 30(4):758-64. PubMed ID: 15526000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Role for Sigma Receptors in Stimulant Self-Administration and Addiction.
    Katz JL; Hiranita T; Hong WC; Job MO; McCurdy CR
    Handb Exp Pharmacol; 2017; 244():177-218. PubMed ID: 28110353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 7. Methylphenidate transdermal system in attention-deficit hyperactivity disorder in children: A viewpoint by Raul R. Silva.
    Silva RR
    Drugs; 2006; 66(8):1127-8; discussion 1128. PubMed ID: 16789798
    [No Abstract]   [Full Text] [Related]  

  • 8. [The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents].
    Frölich J; Banaschewski T; Spanagel R; Döpfner M; Lehmkuhl G
    Z Kinder Jugendpsychiatr Psychother; 2012 Sep; 40(5):287-99; quiz 299-300. PubMed ID: 22869222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects.
    Leonard BE; McCartan D; White J; King DJ
    Hum Psychopharmacol; 2004 Apr; 19(3):151-80. PubMed ID: 15079851
    [No Abstract]   [Full Text] [Related]  

  • 10. Safe and effective methylphenidate therapy in a pediatric patient with glaucoma.
    Lewis H; Lewis J
    Atten Defic Hyperact Disord; 2012 Mar; 4(1):37-9. PubMed ID: 22311620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of withdrawal of Ritalin LA in the Western Cape.
    Donker Fv; Riordan G; Wilmshurst J
    S Afr Med J; 2008 Aug; 98(8):570. PubMed ID: 18928026
    [No Abstract]   [Full Text] [Related]  

  • 12. Dexmethylphenidate (Focalin) for ADHD.
    Med Lett Drugs Ther; 2002 May; 44(1130):45-6. PubMed ID: 12011757
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methylphenidate misuse].
    Bruggisser M; Bodmer M; Liechti ME
    Praxis (Bern 1994); 2012 Feb; 101(5):299-305. PubMed ID: 22377977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV; Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.
    Kraemer M; Uekermann J; Wiltfang J; Kis B
    Clin Neuropharmacol; 2010 Jul; 33(4):204-6. PubMed ID: 20571380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies.
    Volkow ND; Fowler JS; Wang GJ; Ding YS; Gatley SJ
    Eur Neuropsychopharmacol; 2002 Dec; 12(6):557-66. PubMed ID: 12468018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of stimulant medications for ADHD.
    Natl Bur Econ Res Bull Aging Health; 2014; (1):1-2. PubMed ID: 25141389
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.
    Merkel RL; Kuchibhatla A
    Expert Opin Drug Saf; 2009 Nov; 8(6):655-68. PubMed ID: 19785509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of methylphenidate: insights from PET imaging studies.
    Volkow ND; Fowler JS; Wang G; Ding Y; Gatley SJ
    J Atten Disord; 2002; 6 Suppl 1():S31-43. PubMed ID: 12685517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulant medication to treat attention-deficit/hyperactivity disorder.
    Santosh P
    BMJ; 2017 Jul; 358():j2945. PubMed ID: 28710152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.